North Carolina ADAP to limit Fuzeon to 25 people
BY Advocate.com Editors
June 02 2003 11:00 PM ET
Because of the high price of the HIV fusion inhibitor Fuzeon, marketed by Roche and Trimeris, the North Carolina AIDS Drug Assistance Program will limit access to the drug to just 25 patients, the Charlotte Observer reports. North Carolina's ADAP has about 2,800 enrollees and an annual budget of $24 million. Because Fuzeon carries a price tag of just under $20,000 for a one-year supply, the program can afford to pay for the medication for only 25 enrollees at a cost of about a half-million dollars. The state's Medicaid program, which also provides health care to many HIV-positive North Carolina residents, announced that it also will cover Fuzeon but has not placed a cap on the number of patients who can qualify for the medication. State ADAP officials say Fuzeon eligibility will be determined on a variety of medical criteria and the order in which program participants sign up for coverage.
- WATCH: The Best of LGBT Chorus Holiday Music
- Op-ed: Two and a Half Men Introduces Trans Character, Manages to Stay Respectful
- New Gay U.S. Ambassador Meets With Dominican President
- PHOTOS: We Asked The Stars, Who Is Your Hero?
- WATCH: Obama Invokes LGBT Rights in Mandela Eulogy
- WATCH: The 12 Gayest Holiday Spectaculars Ever!
- Media Russia Expert to Offer Political Commentary During Olympics 8 min 36 sec ago
- Travel In-Flight Cellphone Conversations: Dream or Nightmare? 16 min 10 sec ago
- Politics New Gay U.S. Ambassador Meets With Dominican President 56 min 44 sec ago
- Latest News NBC To Spotlight Russia’s Human Rights Abuses During Olympics 1 hour 53 min ago
- Couples/Personal Finances The Financial Effects of DOMA: Filing Taxes 2 hours 8 min ago
- Couples/Personal Finances Examining Employee Benefits in the Wake of DOMA’s Overturn 2 hours 26 min ago
- Women Pussy Riot To Be Freed 2 hours 39 min ago